New FDA Draft Guidance – A Risk-Based Approach to Monitoring of Clinical Investigations - May 14 - 14, 2019 - Online Training; 1:00 - 2:30 PM EDT US

Get more Life Science Leader insight with our FREE newsletter. sign me up

Home

Past Issues Digital Edition

New FDA Draft Guidance – A Risk-Based Approach to Monitoring of Clinical Investigations

May 14 - 14, 2019 - Online Training; 1:00 - 2:30 PM EDT US

LSTI

Get the latest articles from Life Science Leader delivered to your inbox.

I agree to the Terms.

I agree to the Privacy Statement.

This website uses cookies to ensure you get the best experience on our website. Learn more